Do you represent this company?
If YES, Claim your Life Science profile on SOURCE EXPLORER to get connected with top Life Science Professionals.

Supplier Logo

Evidera

United States

Overview

Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.

Areas of subspecialty

Strategic and Tactical Planning
Pricing Strategy and Communications
Channel Strategy and Engagement
Contracting Strategy and Execution
Payer Segmentation
Pre-launch Unmet Needs Campaigns
Value Propositions
Payer Promotions
Health Economic - RWE and FDAMA 114 Communications
AMCP Dossiers
Account Team Planning and Training
Reimbursement Support Programs
Patient Affordability Materials
Payer Media Planning
Pull-through Programs
Market Research / Advisory Boards
Areas of service
  • North America